Skip navigation


Featured Events
CBI Blog

5 Initiatives to Advance Research into Rare Disease Therapies
Linda K (Aug 28, 2014)
Rare diseases have traditionally received far less attention from legislators, researchers and pharmaceutical companies than more prevalent health issues. Rare diseases have often been overlooked because of a myraid of reasons including: lack of research on the disease state, difficulty in finding and retaining patients to participate in clinical trials, getting coverage approvals from payers, spreading market awareness about the disorder, and the financial return of such therapies.

Related Conference: NORD's Rare Diseases and Orphan Products Breakthrough Summit

See all CBI blog posts >>